Tammy H Cummings

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Angiotensin Converting Enzyme

Patient Satisfaction

Cognitive Impairment

Top Venues

Pharmacy (Basel, Switzerland)

Journal of thrombosis and thrombolysis

medRxiv : the preprint server for health sciences

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, Ilya Tyagin, Ilya Safro, Michael D Wyatt, Michael S Shtutman, S Scott Sutton
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virus. medRxiv : the preprint server for health sciences (2024)
Tammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, Ilya Tyagin, Ilya Safro, Michael D Wyatt, Michael S Shtutman, S Scott Sutton
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virus. medRxiv : the preprint server for health sciences (2024)
S Scott Sutton, Joseph Magagnoli, Tammy H Cummings, Theresa Dettling, Belinda Lovelace, Mary J Christoph, James W Hardin
Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of thrombosis and thrombolysis (2023)
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, Tammy H Cummings, James W Hardin, S Scott Sutton, Jayakrishna Ambati
Association between Fluoxetine Use and Overall Survival among Patients with Cancer Treated with PD-1/L1 Immunotherapy. Pharmaceuticals (Basel, Switzerland) 16 (5) (2023)
S Scott Sutton, Joseph Magagnoli, Tammy H Cummings, Theresa Dettling, Belinda Lovelace, Mary J Christoph, James W Hardin
Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. Journal of thrombosis and thrombolysis (2023)
Carrington Royals, Reagan K Barfield, Mary Francis Newman, Lori Mor, Tammy H Cummings, Paul Brandon Bookstaver
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Carrington Royals, Reagan K Barfield, Mary Francis Newman, Lori Mor, Tammy H Cummings, Paul Brandon Bookstaver
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Carrington Royals, Reagan K Barfield, Mary Francis Newman, Lori Mor, Tammy H Cummings, Paul Brandon Bookstaver
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Carrington Royals, Reagan K Barfield, Mary Francis Newman, Lori Mor, Tammy H Cummings, Paul Brandon Bookstaver
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits. Pharmacy (Basel, Switzerland) 10 (6) (2022)
Carrington Royals, Reagan K Barfield, Mary Francis Newman, Lori Mor, Tammy H Cummings, Paul Brandon Bookstaver
Impact of Clinical Pharmacy Expansion within a Rural Federally Qualified Health Center through Implementation of Pharmacist-Led Medicare Annual Wellness Visits. Pharmacy (Basel, Switzerland) 10 (6) (2022)
S Scott Sutton, Joseph Magagnoli, Tammy H Cummings, James W Hardin
Melatonin as an Antimicrobial Adjuvant and Anti-Inflammatory for the Management of Recurrent Clostridioides difficile Infection. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Tammy H Cummings, Joseph Magagnoli, James W Hardin, S Scott Sutton
Drug repurposing of dextromethorphan as a cellular target for the management of influenza. Pharmacotherapy 41 (10) (2021)